Purchase by Versant Venture Capital VI, L.P., Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage I, L.P., Versant Vantage I GP, L.P., Versant Vantage I GP-GP, LLC
Monte Rosa Therapeutics, Inc.
Transaction date
- Shares
- 157,895
- Price per share
- 19.00